🔎 Trials Near Me

Hjem › Tripelnegativ brystkræft › Florida

Tripelnegativ brystkræft kliniske forsøg i Florida

47 studier for Tripelnegativ brystkræft søger deltagere på steder i Florida.

Byer i Florida

Officiel studietekst (engelsk)

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • University of Miami - Sylvester Comprehensive Cancer Center, Miami
  • Advent Health, Orlando
  • Florida Cancer Specialists South, Port Charlotte
RekruttererFase 1/2
Alder 12 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT04585750

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

  • AdventHealth Cancer Institute, Orlando
RekruttererFase 1
Alder 19 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT06586957

Study of AVZO-021 in Patients With Advanced Solid Tumors

  • Avenzo Therapeutics Recruiting Site, Sarasota
  • Avenzo Therapeutics Recruiting Site, Tampa
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT05867251

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

  • Baptist MD Anderson Cancer Center, Jacksonville
Rekrutterer
Alder 30 og opefter · Kvinder · Opdateret 25. sep. 2026 · NCT02945579

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

  • AdventHealth Medical Group Oncology and Hematology at Altamonte ( Site 0044), Altamonte Springs
  • Florida Cancer Specialists - South ( Site 7004), Fort Myers
  • Bioresearch Partner ( Site 0072), Hialeah
  • og 2 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06966700

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

  • Mayo Clinic Jacksonville, Jacksonville
  • Moffitt Cancer Center, Tampa
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT04981119

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

  • AdventHealth Altamonte Springs ( Site 0125), Altamonte Springs
  • Orlando Health Cancer Institute ( Site 0030), Orlando
  • Comprehensive Hematology Oncology ( Site 0091), St. Petersburg
  • og 1 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06393374

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

  • AdventHealth Medical Group Oncology and Hematology at Altamonte ( Site 0007), Altamonte Springs
  • Orlando Health Cancer Institute ( Site 0012), Orlando
  • Florida Cancer Specialists - East ( Site 7000), West Palm Beach
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06841354

Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer

  • Morton Plant Hospital - Baycare Health System, Clearwater
  • Moffitt Cancer Center, Tampa
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT05528133

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

  • University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT06618287

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

  • Sylvester Comprehensive Cancer Center, Miami
  • Sara Cannon Research Institute Lake Nona, Orlando
  • Hematology - Oncology Associates of the Treasure Coast, Port Saint Lucie
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT05983432

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

  • Biogenix Molecular, LLC, Miami
  • Advent Health Medical Group Radiation Oncology at Central Florida, Orlando
  • Moffitt Cancer Center, Tampa
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 17. sep. 2026 · NCT07020117

Study of Screening Brain MRIs in Stage IV Breast Cancer

  • Morton Plant Mease- Baycare, Clearwater
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT05115474

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

  • University of Miami, Miami
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 11. sep. 2026 · NCT06657222

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

  • Mayo Clinic Florida, Jacksonville
  • Cancer Specialists of North Florida, Jacksonville
  • Jupiter Medical Center, Jupiter
  • og 4 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT05633654

Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer

  • UM Sylvester Comprehensive Cancer Center at Aventura, Aventura
  • UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
  • og 7 flere
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT03606967

A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer

  • BAPTIST ALLIANCE - MCI (Data Collection Only), Miami
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT05570253

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

  • Cleveland Clinic Florida, Weston
RekruttererObservationsstudie
Alder 18 til 99 · Alle køn · Opdateret 3. sep. 2026 · NCT07211178

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

  • SCRI Florida Cancer Specialists - Sarasota, Sarasota
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 28. aug. 2026 · NCT07029399

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

  • Mayo Clinic in Florida, Jacksonville
RekruttererFase 1/2
Alder 16 og opefter · Alle køn · Opdateret 20. aug. 2026 · NCT05269381

SMP-3124LP in Adults With Advanced Solid Tumors

  • Advent Health, Celebration
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 12. aug. 2026 · NCT06526819

DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs

  • Miami Baptist Cancer Institute/, Miami
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 6. aug. 2026 · NCT06176261

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

  • USOR Florida Cancer Specialists South, Fort Myers
  • USOR Florida Cancer Specialists North, St. Petersburg
  • USOR Florida Cancer Specialists East, West Palm Beach
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 4. aug. 2026 · NCT05579366

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

  • Mayo Clinic Jacksonville, Jacksonville
RekruttererFase 1
Alder 18 til 100 · Alle køn · Opdateret 29. jul. 2026 · NCT06562192

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

  • Florida Cancer Specialists - Lake Nona, Orlando
  • Florida Cancer Specialists - Sarasota, Sarasota
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 28. jul. 2026 · NCT06150664

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

  • Mayo Clinic - Jacksonville, Jacksonville
  • Florida Cancer Specialists, Sarasota
  • Moffitt Cancer Center, Tampa
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 29. jun. 2026 · NCT05377996

A Study of LY4175408 in Participants With Advanced Cancer

  • Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute, Orlando
  • Florida Cancer Specialists - Sarasota, Sarasota
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. jun. 2026 · NCT07046923

Study of XB010 in Subjects With Solid Tumors

  • Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 22. jun. 2026 · NCT06545331

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

  • Florida Cancer Specialists, Sarasota
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 18. jun. 2026 · NCT07503808

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

  • University of Miami Health System, Coral Gables
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 15. jun. 2026 · NCT05768932

MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors

  • Moffitt Cancer Center, Tampa
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 11. jun. 2026 · NCT05076760

Phase 1 Study of CLR 125 in Triple Negative Breast Cancer

  • Mayo Clinic Florida, Jacksonville
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 3. jun. 2026 · NCT07311993

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

  • H. Lee Moffitt Cancer Center and Research Institute, Tampa
  • Moffitt Cancer Center, Tampa
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 6. maj 2026 · NCT01042379

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

  • Miami Cancer Institute at Baptist Health (Kendall), Miami
  • Miami Cancer Institute at Baptist Health, Plantation
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 29. apr. 2026 · NCT04468061

Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy

  • Moffitt Cancer Center, Tampa
RekruttererTidlig fase 1
Alder 18 og opefter · Alle køn · Opdateret 1. apr. 2026 · NCT06435351

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

  • Baptist Alliance - McI, Miami
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 27. feb. 2026 · NCT03808337

DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer

  • Moffitt Cancer Center, Tampa
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 5. feb. 2026 · NCT05504707

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.